$TGTX Sixth Ranked Target on Jefferies Biotech Buyout List. Tough decision for any potential acquirer. Buy now while it's relatively cheap and risk a CRL in CLL, or wait until FDA approval and pay much, much more? Hmmm
10
2
2 Likes